- Home
- LEDS vs INDP Comparison
LEDS vs INDP Comparison
Compare LEDS & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEDS
- INDP
- Stock Information
- Founded
- LEDS 2005
- INDP 2000
- Country
- LEDS Taiwan
- INDP United States
- Employees
- LEDS N/A
- INDP N/A
- Industry
- LEDS Semiconductors
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- LEDS Technology
- INDP Health Care
- Exchange
- LEDS Nasdaq
- INDP Nasdaq
- Market Cap
- LEDS 9.5M
- INDP 10.2M
- IPO Year
- LEDS 2010
- INDP N/A
- Fundamental
- Price
- LEDS $1.73
- INDP $0.95
- Analyst Decision
- LEDS
- INDP Strong Buy
- Analyst Count
- LEDS 0
- INDP 2
- Target Price
- LEDS N/A
- INDP $8.50
- AVG Volume (30 Days)
- LEDS 602.6K
- INDP 24.2K
- Earning Date
- LEDS 01-10-2025
- INDP 03-12-2025
- Dividend Yield
- LEDS N/A
- INDP N/A
- EPS Growth
- LEDS N/A
- INDP N/A
- EPS
- LEDS N/A
- INDP N/A
- Revenue
- LEDS $4,794,000.00
- INDP N/A
- Revenue This Year
- LEDS N/A
- INDP N/A
- Revenue Next Year
- LEDS N/A
- INDP N/A
- P/E Ratio
- LEDS N/A
- INDP N/A
- Revenue Growth
- LEDS N/A
- INDP N/A
- 52 Week Low
- LEDS $0.92
- INDP $0.81
- 52 Week High
- LEDS $2.48
- INDP $3.10
- Technical
- Relative Strength Index (RSI)
- LEDS 68.48
- INDP 52.27
- Support Level
- LEDS $1.22
- INDP $0.82
- Resistance Level
- LEDS $2.48
- INDP $0.89
- Average True Range (ATR)
- LEDS 0.20
- INDP 0.08
- MACD
- LEDS 0.04
- INDP 0.01
- Stochastic Oscillator
- LEDS 40.48
- INDP 54.92
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.